The rising prevalence in GLP-1 agonists for diabetes has led to a debate about delivery routes : skin-applied devices versus pills . Usually , GLP-1 therapies were only available in tablet form, but the https://laraeger484201.blogrelation.com/47582650/glp-1-skin-applications-vs-oral-medications-which-right-for-individuals